ARCHIVES

Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays 11 Concept Contract Recompetitions

October 26, 1984

Drug Development Effort Criticized

April 18, 1975

States Join Suit Alleging Amgen Offered Illegal Kickback To Doctors For Aranesp

November 6, 2009

Nine Saturation Program Planning Winners Names NCI May Reissue RFP Later This Year

May 23, 1975

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

November 15, 2013

NIH Director’s Office Funds $106 Million In Cancer Grants With Stimulus Dollars

September 18, 2009